- Home
- HYFT vs PMVP Comparison
HYFT vs PMVP Comparison
Compare HYFT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | PMVP |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 59.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HYFT | PMVP |
|---|---|---|
| Price | $1.40 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 422.4K | 298.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $51.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.81 |
| 52 Week High | $3.25 | $1.84 |
Technical Indicators
Market Signals| Indicator | HYFT | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 35.27 | 44.66 |
| Support Level | $1.36 | $1.08 |
| Resistance Level | $1.65 | $1.25 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 6.90 | 26.23 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.